Compare URG & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | URG | TLRY |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medicinal Chemicals and Botanical Products |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 699.3M | 688.9M |
| IPO Year | 2006 | 2018 |
| Metric | URG | TLRY |
|---|---|---|
| Price | $1.34 | $4.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 4 |
| Target Price | $2.57 | ★ $72.33 |
| AVG Volume (30 Days) | ★ 14.7M | 3.4M |
| Earning Date | 05-08-2026 | 04-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $27,207,000.00 | N/A |
| Revenue This Year | $200.42 | $8.79 |
| Revenue Next Year | $98.46 | $19.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.01 | $0.39 |
| 52 Week High | $2.35 | $15.70 |
| Indicator | URG | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 38.33 | 33.33 |
| Support Level | $1.32 | $1.14 |
| Resistance Level | $1.39 | $5.71 |
| Average True Range (ATR) | 0.13 | 0.25 |
| MACD | -0.03 | -0.01 |
| Stochastic Oscillator | 12.26 | 15.71 |
Ur-Energy Inc is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located in Wyoming. The company owns and operates the Lost Creek in-situ recovery uranium facility in south-central Wyoming, Lost Creek received an amendment to its license allowing the expansion of mining activities within the existing Lost Creek Project and the adjacent LC East Project; Shirley Basin; Other U.S. Projects.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.